MEDIGENE

Welcome to the Brand page for “MEDIGENE”, which is offered here for In the statement, column 1, before line 1, medigene ag, (germany corporation), martinsried, munich, germany, by change of name from, should be inserted.;medicaments for the treatment of [ cardiac, ] cancer [ and metabolic ] diseases in human beings [ and animals ] ; [serums and recombinant proteins as vaccines against cancer and infectious diseases; test kits containing antibodies, enzymes, dna and biochemical solutions for the testing of cardiac diseases, such as congestive heart failure, and cancer diseases, such as cervical and ovarian cancer, melanoma and other epithelial tumors in human beings and animals; diagnostic and therapeutic reagents, such as antibodies, dna, enzymes and biochemical solutions for clinical medical laboratory use in the field of human and veterinary molecular biology, genetic engineering and bioengineering];laboratory research and development of testing methods in the fields of human [ and veterinary ] molecular biology, genetic engineering and bioengineering, screening for pharmaceutically effective compounds;.

Its status is currently believed to be active. Its class is unavailable. “MEDIGENE” is believed to be currently owned by “MEDIGENE AG”.